Influence of time and temperature on coagulation analytes in stored plasma.
There is no comprehensive study on the stability of coagulation analytes in plasma. We therefore determined the influence of storage time and temperature on prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen, factors V and VIII, antithrombin III, protein C and S in plasma from 20 healthy subjects and 20 patients receiving heparin therapy. The stability in plasma, defined as the period during which there was a change of less than 10% from the initial value, was 8 hours for activated partial thromboplastin time, 24 hours for prothrombin time, 48 hours for factor V and 7 days for thrombin time, fibrinogen, protein C and antithrombin III in healthy subjects at 6 degrees C. Factor VIII and protein S showed 19 and 12 % reduction in activity, respectively, after 8 hours. In volunteers not treated with heparin therapy, activated partial thromboplastin time was stable for 8 hours; prothrombin time for 48 hours; and thrombin time, fibrinogen and antithrombin III for 7 days with sample storage at room temperature. Factor VIII showed a decrease of 18 % after 8 hours. For patients receiving heparin therapy, the stability of the analytes in plasma stored at 6 degrees C was 8 hours for thrombin time, 24 hours for prothrombin time and activated partial thromboplastin time and 7 days for fibrinogen and antithrombin III. Factors V and VIII showed a decrease of 13 % and 20 % respectively after 8 hours. When the plasma of these patients was stored at room temperature, factor V was stable for 8 hours, and prothrombin time for 24 hours, whereas fibrinogen and antithrombin III remained unchanged for 7 days. Activated partial thromboplastin time showed an increase of 13 %, thrombin time a fall of 16 %, and factor VIII a decrease of 18 % after 8 hours.
Heil
W
W
Zentrallaboratorium, Klinikum Wuppertal GmbH, Universität Witten/Herdecke, Germany.
Grunewald
R
R
Amend
M
M
Heins
M
M
D001777:Blood Coagulation; D019774:Blood Coagulation Factor Inhibitors / Q000378:metabolism; D001779:Blood Coagulation Factors / Q000378:metabolism*; D001793:Blood Preservation; D001798:Blood Proteins / Q000378:metabolism; D005165:Factor V / Q000378:metabolism; D006801:Humans; D010949:Plasma / Q000378:metabolism*; D013696:Temperature; D013995:Time
D019774:Blood Coagulation Factor Inhibitors; D001779:Blood Coagulation Factors; D001798:Blood Proteins; D005165:Factor V